Phaseline

Targets › PAER

PAER: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Infectious disease.

Open in Phaseline: the race on PAER, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
BiomXBX004
Combination of nebulized bacteriophages targeting Pseudomonas aeruginosa
PAERPhase 2Chronic Pseudomonas Aeruginosa Infection–

Conditions

Chronic Pseudomonas Aeruginosa Infection (1)

Modalities

protein or peptide (1)

Companies

BiomX (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.